Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ipsen Appoints Baxalta's Oncology Chief Meek CEO

Executive Summary

Ipsen has appointed Baxalta's head of oncology David Meek as its new CEO, having formerly instigated a search in February. Baxalta's $32bn acquisition by Shire completed at the start of June.


Related Content

Meek To Drive M&A At Ipsen, Building On Two Major Launches
Precision BioSciences Says Baxalta's IO Focus Made It Preferred Partner


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts